Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

Overview of attention for article published in Breast Cancer Research, July 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 4 news outlets
twitter: 7 X users

patent: 2 patents
facebook: 3 Facebook pages

Citations

dimensions_citation: 69 Dimensions

Readers on

mendeley: 85 Mendeley

Summary News X Patents Facebook Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13RαA2 POSITIVE…

Application WO-2021183960-A1

World Intellectual Property Organisation (WIPO)

TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13Rα2 POSITIVE…

Application WO-2021154543-A2

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.